Cystic fibrosis drug set for rejection

A €220,000 `wonder drug' to treat cystic fibrosis is set to be rejected for use in the Irish health service.

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
20th January, 2013

A €220,000 "wonder drug" to treat cystic fibrosis (CF) is set to be rejected for use in the Irish health service after the manufacturer was told there were serious obstacles to the Irish taxpayer covering the cost.

Kalydeco, which is manufactured by Vertex Pharmaceuticals, is the first and only drug that treats the underlying cause of CF rather than the symptoms of the condition.

It is too early to say whether Kalydeco will be a...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Newsround: What Thursday’s papers say